{
  "report_rows": [
    {
      "kpi": "Adj. EPS (Diluted Operating)",
      "prediction": "BEAT",
      "answer": "pred ~$1.80 vs. cons $1.765",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Japan New Premiums (\u00a5B)",
      "prediction": "BEAT",
      "answer": "pred ~\u00a521.5B vs. cons \u00a520.96B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Japan Benefit Ratio (%)",
      "prediction": "MISS",
      "answer": "pred ~62.5% vs. cons 61.77%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Japan Benefit Ratio FY2026 (FY2026)",
      "prediction": "UNCHANGED",
      "answer": "guide 60-63% reiterated vs. cons 62.07%",
      "confidence": "HIGH"
    },
    {
      "kpi": "U.S. Benefit Ratio FY2026 (FY2026)",
      "prediction": "UNCHANGED",
      "answer": "guide 48-52% reiterated vs. cons 48.43%",
      "confidence": "HIGH"
    },
    {
      "kpi": "Japan FY2026 Sales (FY2026)",
      "prediction": "UNCHANGED",
      "answer": "guide ~JPY 80B reiterated vs. cons JPY 79.0B",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -2.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.0,
  "day5_path": "FADE",
  "day5_rationale": "FADE \u2014 sell-side trims H2 estimates on Japan benefit ratio miss; short covering limits day-1 damage but does not reverse the trend",
  "day5_confidence": "MEDIUM"
}